Validated capillary electrophoresis method for the determination of atropine and scopolamine derivatives in pharmaceutical formulations

Journal of Pharmaceutical and Biomedical Analysis

Volumn 17, Issue 6-7, 1998, Pages 1167-1176

  Cherkaoui, Samir ^a   Mateus, Lidia ^a   Christen, Philippe ^a   Veuthey, Jean Luc ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Atropine and scopolamine derivatives; Capillary electrophoresis; Hydroxypropyl cyclodextrin; Method development and validation; Pharmaceuticals

Indexed keywords

ATROPINE DERIVATIVE; CYCLODEXTRIN DERIVATIVE; FLUTROPIUM BROMIDE; IPRATROPIUM BROMIDE; OXITROPIUM BROMIDE; SCOPOLAMINE BUTYL BROMIDE; SCOPOLAMINE DERIVATIVE;

AEROSOL; ARTICLE; CAPILLARY ELECTROPHORESIS; CAPILLARY ZONE ELECTROPHORESIS; DRUG DETERMINATION; DRUG FORMULATION; INJECTION; PRIORITY JOURNAL; SUPPOSITORY; TABLET; TECHNIQUE;

ATROPINE DERIVATIVES; BETA-CYCLODEXTRINS; CYCLODEXTRINS; DRUG CONTAMINATION; ELECTROPHORESIS, CAPILLARY; HYDROGEN-ION CONCENTRATION; REPRODUCIBILITY OF RESULTS; SCOPOLAMINE DERIVATIVES; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 0032422810     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(98)00083-1     Document Type: Article

References (23)

1. [1] W.C. Evans, Trease and Evans' Pharmacognosy 14th edn., 1996, W.B. Sanders (London) pp. 346-358.
2. [2] J.G. Hardman, L.E. Limbird (Eds.), Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 1995, Mc Graw Hill (New York) pp. 141-160.
3. [3] S.R. El-Shabouri, S.A. Hussin, A.M. Taha, K.M. Imera, Bull. Pharm. Sci. 8 (1985) 120.
4. [4] T. Aman, A. Hassan, I. Khokhar, A. Rashid, Anal. Lett. 27 (1994) 1833.
5. [5] J. Pohjola, M. Harpf, J. Chromatogr. A 686 (1994) 350.
6. [6] C. Van Buuren, J.F. Lawrence, U.A.Th. Brinkman, I.L. Honigberg, R.W. Frei, Anal. Chem. 52 (1980) 700.
7. [7] P. Majlat, J. Chromatogr. A 241 (1982) 399.
8. [8] R.L. Ballbach, D.J. Brown, S.M. Walters, J. Pharm. Sci. 71 (1977) 1553.
9. [9] R.A. de Zeeuw, J.P. Franke, M. van Halem, S. Schaapman, E. Logawa, C.J.P. Siregar, J. Chromatogr. A 664 (1994) 263.
10. [10] U. Lund, S.H. Hansen, J. Chromatogr. 161 (1978) 371.
11. [11] J.C. Gfeller, G. Frey, J.M. Huen, J.P. Thevenin, J. Chromatogr. 112 (1979) 141.
12. [12] M. Takahashi, M. Nagashima, S. Shigeoka, M. Nishijima, K. Kamata, J. Chromatogr. A 775 (1997) 137.
13. [13] O.-W. Lau, C.-S. Mok, J. Chromatogr. A 766 (1997) 270.
14. [14] I.D. Cruzado, G. Vigh, J. Chromatogr. 608 (1992) 421.
15. [15] Y.Y. Rawjee, R.L. Williams, G. Vigh, J. Chromatogr. A 680 (1994) 599.
16. [16] S. Cherkaoui, L. Mateus, P. Christen, J.L. Veuthey, J. Chromatogr. B 696 (1997) 283.
17. [17] S. Cherkaoui, L. Mateus, P. Christen, J.L. Veuthey, Chromatographia 46 (1997) 351.
18. [18] G. Blaschke, E. Lamparter, J. Schluter, Chirality 5 (1993) 78.
19. [19] I. Bjornsdottir, S.H. Hansen, J. Pharm. Biomed. Anal. 13 (1995) 687.
20. [20] S. Fanali, in: N.A. Guzman (Ed.), Capillary electrophoresis technology, Marcel Dekker, New York, 1993, p. 731.
21. [21] D. Duchêne, D. Wouessidjewe, Physicochemical characteristics and pharmaceutical uses of cyclodexlrin derivatives, Pharm. Technol. Int. (1990) 21.
22. [22] A. Bunke, T. Jira, T. Beyrich, J. Chromatogr. A 728 (1996) 441.
23. [23] K.D. Altria, D.R. Rudd, Chromatographia 41 (1995) 325.